Cidara Therapeutics (NASDAQ:CDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Cidara Therapeutics beat estimated earnings by 6.9%, reporting an EPS of $-0.27 versus an estimate of $-0.29.
Revenue was up $4.70 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 1.75% increase in the share price the next day.
Here’s a look at Cidara Therapeutics’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.36 | -0.08 | -0.31 |
| EPS Actual | -0.26 | -0.37 | 0.18 | -0.39 |
| Revenue Estimate | 4.31M | 2.94M | 18.20M | 8.33M |
| Revenue Actual | 7.22M | 7.08M | 32.86M | 2.41M |
To track all earnings releases for Cidara Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
